Abstract Library

#4510 Follow-up analysis of group nutritional education in patients with neuroendocrine neoplasms (GEDNEN Course): A novel approach with proven acceptability

Introduction: Structured group education demonstrates improved outcomes in peri-operative health optimisation and diabetes mellitus. We devised and delivered a novel in person nutrition/dietary education programme for patients with neuroendocrine neoplasms (NENs) at the Sheffield ENETS Centre of Excellence.

Conference:

Presenting Author: Munir A

Authors: Wen Loh E, Walsh E, Bisson H, Ahmed Z, Dancyger-Stevens L,

Keywords: Group Education, Nutrition, Neuroendocrine Neoplasm, Novel Tool,

#3849 Is patient's BMI representative of their body composition in neuroendocrine tumors?

Introduction: Up to 60% of patients with neuroendocrine tumors (NETs) are malnourished. This negatively impacts survival, length of hospital stay, risk of complications, treatment response, fatigue and quality of life. Malnutrition is typically defined by body mass index (BMI) or weight loss, which provides no information on body composition. Research in other cancers has shown sarcopenia is more significant than BMI. Information is lacking on the influence of anthropometric parameters in NETs.

Conference:

Presenting Author: Bradley E

Authors: Bradley E, Shah T,

Keywords: neuroendocrine, body composition, handgrip strength, mid arm muscle circumference,

#3690 Development of a novel NET-nutrition screening tool to identify patients requiring nutrition-related intervention and support

Introduction: Patients with neuroendocrine tumors (NET) are at risk of malnutrition, nutrient malabsorption and dietary change. Existing validated malnutrition risk screening tools are not designed to capture complex NET-related nutrition issues.

Conference:

Presenting Author: Laing E

Authors: Laing E, Kiss N, Loeliger J, Steer B, Michael M,

Keywords: neuroendocrine, nutrition, screening, diet,

#3560 Nutritional status in patients with neuroendocrine tumors: A single ENETS Centre of Excellence experience

Introduction: Studies show that 14–68% of patients with neuroendocrine tumors (NETS) are at risk of or are malnourished. Patients’ dependent on NET type, primary or treatment are at risk of Vitamin B12, A, D E, iron deficiencies, pancreatic enzyme insufficiency (PEI) and a high HbA1c.

Conference:

Presenting Author:

Authors: Burke D, Almeamar H, O'Toole D, Barnes L, Crowley R,

Keywords: malnutrition, deficiencies, Pancreatic enzyme insufficiency, HbA1c's,

#3379 Survey of neuroendocrine tumor patients’ experience of quality of care provided by a dedicated NET Dietitian

Introduction: The Birmingham Neuroendocrine Tumour (NET) service has a full time dedicated NET Dietitian for outpatient and inpatient care since August 2020.

Conference:

Presenting Author: Mair R

Authors: Mair R, Bradley E, Davis N, Shah T,

Keywords: net, DIETITIAN, QUALITY OF LIFE, SYMPTOM CONTROL,